Since non-specific activation of CD4+ T cells can enhance FIV and HIV-1 infection [4,37], the selection of conserved protective peptide pools was based predominantly on CD8+ T-cell responses and to a lesser degree on CD4+ CTL activity. The gene discussed is CD8A; the disease is HIV-1 infection.